Background: Visible light is a treatment option for segmental vitiligo (SV), and visible light-induced repigmentation is associated with normalization of sympathetic dysfunction. Currently, it is difficult to predict individual patients' response to visible light therapy.
Objectives: To test whether cutaneous blood flow can serve as a response predictor for visible light on treating SV.